Galenix Innovations

GALENIX INNOVATIONS is an innovative technology platform focusing on drug delivery solutions for life cycle management, new chemical entities, Biologicals or mature molecules using conventional dosage forms or its own patented technologies.

Our highly qualified formulation and analytical development team has a very important expertise and experience on wide range of pharmaceutical formulations for human and veterinary use. Our extensive international know-how allows to secure your development program and offers you innovative and optimised drug products.

        GALENIX INNOVATIONS platform includes two departments:
                Drug Delivery System (DDS) department
                Early development department

The mission of the DDS department is to bring solutions for the improvement patient compliance and formulations with controlled release technologies with suprabioavailability, delayed, extended as well as immediate release and for oral, topical or parental administrations.
Before launching a development program and considering a licensing-out, this department assesses the compatibility of the molecule with the most suited technology enhancing its therapeutic properties or allowing a better compliance of the patient.


The early development department offers a full range of pharmaceutical services for the formulation development of Rx, OTC or generic products with conventional or innovative dosage forms including:

  • Preformulation
  • Formulation
  • Process transfer and Scale-up
  • Analytical development and validation
  • Quality control
  • Support services for clinical supply 
  • ICH stability studies
  • Regulatory services
  • Consulting

 

 

GALENIX INNOVATIONS - Allee des Palanques - 33127 ST JEAN D'ILLAC - FRANCE

Tel: +33 (0)826 39 69 18 - Fax: +33 (0)5 56 68 83 01